Log inSign up
C. Michael Gibson MD
89.1K posts
C. Michael Gibson MD profile banner
@CMichaelGibson

C. Michael Gibson MD

@CMichaelGibson
Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor clinicaltrialresults.org | RT ≠ endorse | Disclaimer: bit.ly/1mewZOF
Harvard Professor & MD
linkedin.com/in/cmichaelgib…
Joined October 2012
360.1K
Following
429.6K
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    @CMichaelGibson
    C. Michael Gibson MD
    @CMichaelGibson
    Mar 29, 2020
    “The Last Shift” Oil on clay covered wood board by C. Michael Gibson 2020. Welcome home to all of our courageous #CoronaHeroes who made the ultimate sacrifice 🙏💙 #cmgsees #COVID19
    Image
    290
  • @CMichaelGibson
    C. Michael Gibson MD
    @CMichaelGibson
    14h
    How reproducible is AI-enabled coronary plaque quantification? Dr. Jonathon Leipisic and I discuss a new study published in JACC: Advances, where researchers evaluated the interobserver and intraobserver reproducibility of AI-informed coronary CT angiography (CCTA)–derived
    Image
    00:00
  • @CMichaelGibson
    C. Michael Gibson MD
    @CMichaelGibson
    Sep 6
    I have not been able to locate any public announcement confirming the HERMES phase 3 trial of #Ziltivekimab in HFpEF been halted. Does anyone have a link to a press release or a public announcement?
    This post is unavailable.
    5
  • @CMichaelGibson
    C. Michael Gibson MD
    @CMichaelGibson
    Sep 5
    Some take aways from what we know about HORIZONS phase 3 trial of Lp(a) lowering 1. We know very little. We only know the primary endpoint in the entire population. 2. We do not know if some subgroups may have benefited more like those with a higher baseline Lp(a). 3. Do those
    10
  • @CMichaelGibson
    C. Michael Gibson MD
    @CMichaelGibson
    Sep 5
    Recent guidelines give a class 1 indication (strongly recommended) to calcium score testing and Lp(a) testing. The effectiveness of both in improving outcomes has now been unsubstantiated in randomized trials. Should they be downgraded in the guidelines? Why or why not?
    Yes. Downgrade62.2%
    No. Keep as Class 1 rec18.8%
    Show results19%
    548 votesFinal results
    6
Advertisement
Advertisement